• Clients
  • Products
    • iConnect
    • Appbakery
    • CureTalks
  • Team
  • Resources
    • Press
    • Newsletters
    • Webinars
  • Contact Us
  • Blog

  • iConnect
  • Appbakery
  • CureTalks

Logo Logo Logo Logo Logo
  • Clients
  • Products
  • Team
  • Resources
    • Press
    • Newsletters
    • Webinars
  • Contact Us
  • Blog
  • Clients
  • Products
  • Team
  • Resources
    • Press
    • Newsletters
    • Webinars
  • Contact Us
  • Blog

Conquering Cancer from Within. Immunotherapy, the new Hope

23 Apr

Conquering Cancer from Within. Immunotherapy, the new Hope

by TrialX Editor

Conquering Cancer from Within. Immunotherapy, the new Hope

Avatar
TrialX Editor
powerfunction@gmail.com
No Comments

Sorry, the comment form is closed at this time.

Recent Posts

    24 Dec

  • iConnect for the Holidays:
  • 30 Oct

  • When TeleGhosts Haunt: A Spooky Tale of Phone Numbers, Clinical Trials and Politics
  • 19 Oct

  • CureTalks Launches New Talk Series on Contribution of Small Biotech Companies Towards Drug Development of Orphan Diseases
  • 30 Sep

  • Time surveys to get right responses - A fresh way to create and edit time-bound surveys on Appbakery
  • 29 Sep

  • TrialX PCOS Tracker proudly sponsors the PCOS Challenge 5K run in New York City aimed at raising PCOS awareness & PCOS research funding.
  • 10 Sep

  • TrialX's Sleep Tracking and Self Management App gets published in SLEEP, the Journal of Sleep and Sleep disorders research.
  • 11 Aug

  • COVID-19 Clinical Research Part 5: Black Lives Matter (to Research Too!).
  • 10 Aug

  • ResearchKit App Tracking Medication Use, Quality of Life in Neurogenic Pain Patients for a Northwestern University Study - TrialX Appbakery Releases Zing PainApp
  • 07 Aug

  • Rett Syndrome Clinical Trial Finder is LIVE!
  • 23 Jul

  • CureTalks launches New Video Format with a talk series on Covid-19 Research at Penn Medicine
Trial X

Trialx_color_logo

Phone: (212) 537-6944 | Email: info@trialx.com | 315 Fifth Avenue, 9th Floor, New York, NY 10016

© TrialX Inc. 2008-2020